Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026827 (
hypotonia
)
5,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
RSRC1
, whose polymorphism is associated with altered brain function in schizophrenia, is a member of the serine and arginine rich-related protein family. Through homozygosity mapping and whole exome sequencing we show that
RSRC1
mutation causes an autosomal recessive syndrome of intellectual disability, aberrant behaviour,
hypotonia
and mild facial dysmorphism with normal brain MRI. Further, we show that
RSRC1
is ubiquitously expressed, and that the
RSRC1
mutation triggers nonsense-mediated mRNA decay of the
RSRC1
transcript in patients' fibroblasts. Short hairpin RNA (shRNA)-mediated lentiviral silencing and overexpression of
RSRC1
in SH-SY5Y cells demonstrated that
RSRC1
has a role in alternative splicing and transcription regulation. Transcriptome profiling of
RSRC1
-silenced cells unravelled specific differentially expressed genes previously associated with intellectual disability,
hypotonia
and schizophrenia, relevant to the disease phenotype. Protein-protein interaction network modelling suggested possible intermediate interactions by which
RSRC1
affects gene-specific differential expression. Patient-derived induced pluripotent stem cells, differentiated into neural progenitor cells, showed expression dynamics similar to the
RSRC1
-silenced SH-SY5Y model. Notably, patient neural progenitor cells had 9.6-fold downregulated expression of IGFBP3, whose brain expression is affected by MECP2, aberrant in Rett syndrome. Interestingly, Igfbp3-null mice have behavioural impairment, abnormal synaptic function and monoaminergic neurotransmission, likely correlating with the disease phenotype.
...
PMID:RSRC1 mutation affects intellect and behaviour through aberrant splicing and transcription, downregulating IGFBP3. 2952 54